about
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Vinca alkaloidsVincristine-induced peripheral neuropathy in pediatric cancer patientsIndole alkaloids from Catharanthus roseus: bioproduction and their effect on human healthPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.Interactions of antimitotic peptides and depsipeptides with tubulin.Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancerThe challenge of using biomarkers and molecularly targeted drugs to improve cure rate in early stage non-small cell lung cancerGemcitabine in metastatic breast cancer.Synthesis of C-15 vindoline analogues by palladium-catalyzed cross-coupling reactionsPast, present, and future challenges in breast cancer treatment.Resistance to chemotherapy in cancer: a complex and integrated cellular response.Chemotherapy Resistance in Lung Cancer.A 3-D microfluidic combinatorial cell array.Vinflunine in the treatment of bladder cancer.Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes.Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice.Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy.Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs
P2860
Q26781365-55289054-78FE-4789-BEE0-4C103CBABD0DQ26825763-6995EAD9-4C0F-470A-86E3-7220F00B8F2CQ28078232-E2461BDC-F1BC-4CC5-82C7-6AD22003BB08Q28081113-4E70B11D-D5E4-4F6F-8C33-DE7DB2296229Q33744706-FFE64B14-BB34-4567-B58A-0ACC4594C146Q34746035-89AB47CD-A73C-4522-AE34-856EB24D1ADCQ34972878-206CE05C-0F4C-4581-81F2-C07924F6BE04Q35052543-5B057F5A-8EB3-4D5D-A200-3580B641E59FQ35290441-BE4DDB70-9AB6-4AC3-AE9A-19148D16A7EEQ36185611-589539F8-EFB1-455B-A321-75B3948437D9Q36839547-70E492C1-06F2-4F3B-904F-725EACCC2EC8Q36934273-03EF2189-D9ED-47D4-9D08-52B78DD1146CQ37079652-7445CA50-2716-4220-8D15-E3F168FC0489Q38669287-DAE97B2A-E251-4389-A6C2-53EDD1E73905Q39633796-D13F5162-E67A-4586-8A47-2D306ED2027FQ42183149-905585C8-23B2-421F-9FFA-468E396F4293Q42275833-8F863145-661D-4AC5-AB84-B3E89E94E0B7Q42598708-8B73C58C-7B8F-4D6F-AE66-E8C39B9684F7Q43965434-9198F401-5E27-49F0-BBF5-0CD2480275D5Q50074983-A288F938-6494-416C-80F5-170568FC2A2AQ58214998-561B1710-D32F-41AA-82C9-2D6239C6C7EF
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vinorelbine--a clinical review.
@ast
Vinorelbine--a clinical review.
@en
type
label
Vinorelbine--a clinical review.
@ast
Vinorelbine--a clinical review.
@en
prefLabel
Vinorelbine--a clinical review.
@ast
Vinorelbine--a clinical review.
@en
P2860
P356
P1476
Vinorelbine--a clinical review.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1203
P407
P577
2000-06-01T00:00:00Z
P5875
P6179
1030139409